AYM.F : Summary for ALBANY MOLECULAR DL-,01 - Yahoo Finance

U.S. Markets closed

Albany Molecular Research, Inc. (AYM.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
14.81-0.26 (-1.71%)
At close: 4:38PM CEST
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close15.07
Bid14.23 x 26300
Ask14.51 x 25300
Day's Range14.81 - 14.93
52 Week Range11.71 - 17.96
Avg. Volume14
Market Cap644.82M
PE Ratio (TTM)-8.09
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • American City Business Journals4 days ago

    Report: AMRI considering $1 billion sale

    Drug manufacturer Albany Molecular Research Inc. is looking at a $1 billion sale, according to Bloomberg News. AMRI is working with Credit Suisse Group AG to explore a sale, Bloomberg reports, citing unidentified sources. Carlyle Group LP and Pamplona Capital Management, two private equity firms with records of investing in pharmaceutical and health care deals, have expressed interest.

  • PR Newswire5 days ago

    SSCI Receives a 2017 Biotechnology Award for Global Research and Manufacturing

    GHP magazine recognizes that the biotechnology industry is increasingly viewed as being the frontline of medical science, and as this movement continues to gain momentum the publication is committed to following the most game-changing advances and revolutionary developments that will form the healthcare world for years to come. Nathan Angell, GHP awards coordinator, expressed pride in every one of the award winners, "This award recognizes the hard work and dedication of the firms, such as SSCI, and the individuals behind them, that are driving innovation in this vital market.

  • PR Newswire6 days ago

    AMRI Schedules First Quarter 2017 Earnings Release and Conference Call

    ALBANY, N.Y., April 25, 2017 /PRNewswire/ -- AMRI (AMRI) today announced it will issue first quarter 2017 financial results before the opening of the market on Tuesday, May 9, 2017.  Following the release of its results, the company will host a conference call and simultaneous audio webcast at 8:30 a.m. ET. The conference call can be accessed by dialing (866) 208-5728 (domestic calls) or (224) 633-1279 (international calls) at 8:20 a.m. ET and entering passcode 7657377. A replay of the conference call can be accessed for 24 hours at (855) 859-2056 (domestic calls) or (404) 537-3406 (international calls) and entering passcode 7657377.